Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-10-04
1993-03-30
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514192, 514200, 530832, 424439, 426532, 426657, A61K 3702, A61K 3143, A61K 31545, C07K 1300
Patent
active
051984199
ABSTRACT:
Lactoferrin can be used to increase the efficacy of beta-lactam antibiotics. There is a potentiating effect when lactoferrin is administered either simultaneous with or shortly before or after the administration of beta-lactam antibiotics. The dosage of lactoferrin administered is usually 0.5-100 mg/kg and preferably 1-10 mg/kg.
REFERENCES:
patent: 4153686 (1979-05-01), Nagel
patent: 4668771 (1987-05-01), Kawakami et al.
patent: 4726948 (1988-02-01), Prieels et al.
patent: 4977136 (1990-12-01), Nichols et al.
patent: 5019411 (1991-05-01), Johnson et al.
The Merck Manual, Berkow, Editor, pp. 98, 2305-2311, 1982.
Arnold et al., Infection and Immunity 28:893-898, Jun. 1980.
Mochizuki et al., Antimicrobial Agents and Chemotherapy 32: 1648-1654, Nov. 1988.
Ando Kunio
Goto Sachiko
Immuno Japan Inc.
Walsh Stephen
Wax Robert A.
LandOfFree
Formulated medicines for enhancing the efficacy of beta-lactam a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulated medicines for enhancing the efficacy of beta-lactam a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulated medicines for enhancing the efficacy of beta-lactam a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1281077